Heng-Jia Liu

8PUBLICATIONS
26CO-AUTHORS
Cancer cell biologyInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 20, 2026
mTORC1 activation induces B7-H3-dependent metabolic reprogramming in renal cell carcinoma (RCC).

|Jul 02, 2025
From tumor immunity to precision medicine: the next step in B7-H3/CD276 research.

Haolie Fang, Yuqian Liu, Gege Wang

|Jul 16, 2024
Plasmacytoid Dendritic Cells: Bring a Glimmer of Hope for Patients with Lymphangioleiomyomatosis.

Heng Du, Heng-Jia Liu

|Mar 03, 2023
mTORC1 upregulates B7-H3/CD276 to inhibit antitumor T cells and drive tumor immune evasion.

Heng-Jia Liu, Heng Du, Damir Khabibullin

|Sep 21, 2021
Interleukin-6 mediates PSAT1 expression and serine metabolism in TSC2-deficient cells.

Ji Wang, Harilaos Filippakis, Thomas Hougard

|Jul 13, 2021
TSC2 regulates lysosome biogenesis via a non-canonical RAGC and TFEB-dependent mechanism.

Nicola Alesi, Elie W Akl, Damir Khabibullin

Pageof 2

Frequent Collaborators

3 joint publications

Heng Du

3 joint publications

Elizabeth P Henske

2 joint publications

David J Kwiatkowski

2 joint publications

Harilaos Filippakis